PRPO - Precipio, Inc.

4.5
-0.770   -17.111%

Share volume: 29,094
Last Updated: 04-07-2025
Measuring And Control Equipment/Lab Analytical Instruments: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$5.27
-0.77
-0.15%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
12%
Profitability 0%
Dept financing 6%
Liquidity 39%
Performance 20%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-12.62%
1 Month
-37.06%
3 Months
-27.75%
6 Months
-35.62%
1 Year
-30.88%
2 Year
-63.72%
Key data
Stock price
$4.50
P/E Ratio 
N/A
DAY RANGE
$3.90 - $5.30
EPS 
-$2.56
52 WEEK RANGE
$3.90 - $10.74
52 WEEK CHANGE
-$29.13
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
1.482 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
0.15
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$9,015
AVERAGE 30 VOLUME 
$5,235
Company detail
CEO: Ilan Danieli
Region: US
Website: precipiodx.com
Employees: 60
IPO year: 2000
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Precipio, Inc. provides diagnostic blood cancer testing services in the United States. The company sells ICE-COLD-PCR technology kits to bio-pharma customers. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment.

Recent news
loading